Comment on: High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?

被引：1

作者：

Davido, Benjamin ^{[1
]}

Dinh, Aurelien ^{[1
]}

Matt, Morgan ^{[1
,2
]}

Senard, Olivia ^{[1
,2
]}

Deconinck, Laurene ^{[1
,2
]}

Bouchand, Frederique ^{[3
]}

Salomon, Jerome ^{[1
,2
,4
]}

机构：

[1] Hop Raymond Poincare, AP HP, Malad Infect, Grp Hosp Paris Ile France Ouest, F-92380 Garches, France

[2] Univ Versailles St Quentin, F-78180 Versailles, France

[3] Hop Raymond Poincare, AP HP, Pharm, Grp Hosp Paris Ile France Ouest, F-92380 Garches, France

[4] Inst Pasteur, INSERM, UMR 1181, Paris, France

来源：

关键词：

AZTREONAM; STRAIN;

D O I：

10.1093/jac/dkx408

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：828 / 829

页数：2

共 3 条